InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Desai Veeral, Directeur de la Stratégie et du Développement. Director active across 1 companies, notably agilon health, inc.. In total, 7 filings have been published. The latest transaction was disclosed on 24 June 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€101,099106,357 shares@ €0.95060.035% mcap15.4% of flow
Common Stock
SEC:0001209191-22-039598:0·
€73,43579,568 shares@ €0.92290.026% mcap11.2% of flow
Common Stock
SEC:0001209191-22-025550:0·
€98,529106,357 shares@ €0.92640.035% mcap15.0% of flow
Common Stock
SEC:0001209191-22-025160:0·
016,255 shares0
Common Stock
SEC:0001209191-22-025009:0·
€179,856197,291 shares@ €0.91160.063% mcap27.3% of flow
Common Stock
SEC:0001209191-22-020015:0·
€102,500121,001 shares@ €0.84710.036% mcap100.0% of flow
Common Stock
SEC:0001209191-21-056200·
€102,500121,001 shares@ €0.84710.036% mcap15.6% of flow
Common Stock
SEC:0001209191-21-056200:0·
7 of 7 declarations
About Desai Veeral
Veeral Desai is the Chief Strategy & Development Officer at agilon health, inc. He is responsible for developing and implementing the company's growth strategies. His role involves identifying new market opportunities and leading strategic development initiatives. Through his expertise, he contributes to the company's strategic direction and achieving its growth objectives.
